Potential role of uric acid as a biomarker for Parkinson's disease

被引：3
|
作者：
Huang, Yi-Xian [1 ]
Luo, Wei-Feng [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou 215004, Peoples R China
来源：
MEDICAL HYPOTHESES | 2010年 / 75卷 / 02期
关键词：
URATE; PROGRESSION; PREDICTOR; RISK;
D O I：
10.1016/j.mehy.2010.03.030
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [21] Serum uric acid concentration, in patients with Parkinson's disease
    Iwasaki, Y.
    Kawabe, K.
    Kano, O.
    Yoshii, Y.
    Ikeda, K.
    MOVEMENT DISORDERS, 2009, 24 : S527 - S527
  • [22] Serum uric acid as a putative biomarker in Prodromal Parkinson's disease: Longitudinal data from the PPMI study
    Koros, C.
    Simitsi, A. -M.
    Papagiannakis, N.
    Bougea, A.
    Prentakis, A.
    Papadimitriou, D.
    Pachi, I.
    Antonelou, R.
    Angelopoulou, E.
    Efthymiopoulou, E.
    Beratis, I.
    Bozi, M.
    Papageorgiou, S.
    Bonakis, A.
    Stamelou, M.
    Stefanis, L.
    MOVEMENT DISORDERS, 2021, 36 : S279 - S279
  • [23] Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson's Disease: Longitudinal Data from the PPMI Study
    Koros, Christos
    Simitsi, Athina-Maria
    Papagiannakis, Nikolaos
    Bougea, Anastasia
    Prentakis, Andreas
    Papadimitriou, Dimitra
    Pachi, Ioanna
    Beratis, Ion
    Stanitsa, Evangelia
    Angelopoulou, Efthalia
    Antonelou, Roubina
    Bregianni, Marianna
    Lourentzos, Konstantinos
    Papageorgiou, Sokratis G.
    Bonakis, Anastasios
    Trapali, Xenia Geronicola
    Stamelou, Maria
    Stefanis, Leonidas
    JOURNAL OF PARKINSONS DISEASE, 2023, 13 (05) : 811 - 818
  • [24] Low plasma uric acid level in Parkinson's disease
    Annanmaki, Tua
    Muuronen, Antti
    Murros, Kari
    MOVEMENT DISORDERS, 2007, 22 (08) : 1133 - 1137
  • [25] A Pathology-Validated Study to Investigate the Role of Uric Acid in Parkinson's disease (PD)
    Pecoraro, P.
    Carbone, S.
    Di Lazzaro, V.
    di Biase, L.
    MOVEMENT DISORDERS, 2024, 39 : S841 - S842
  • [26] MiR-146 as a potential biomarker for Parkinson's disease
    Ardashirova, N.
    Abramycheva, N.
    Fedotova, E.
    Illarioshkin, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 633 - 633
  • [27] Colonic α-synuclein: a potential diagnostic biomarker in Parkinson's disease
    Ruffmann, C.
    Poggiolini, I.
    Hu, M.
    Parkkinen, L.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2016, 42 : 51 - 51
  • [28] Study of EEG microstates in Parkinson’s disease: a potential biomarker?
    Anita Pal
    Madhuri Behari
    Vinay Goyal
    Ratna Sharma
    Cognitive Neurodynamics, 2021, 15 : 463 - 471
  • [29] Lipopolysaccharide binding protein as a potential biomarker of Parkinson's disease
    Pal, G. D.
    Shaikh, M.
    Forsyth, C. B.
    Keshavarzian, A.
    Shannon, K. M.
    MOVEMENT DISORDERS, 2014, 29 : S258 - S258
  • [30] Colonic α-synuclein: A potential diagnostic biomarker in Parkinson's disease
    Ruffmann, C.
    Poggiolini, I.
    Bengoa-Vergniory, N.
    Baig, F.
    Rolinski, M.
    Klein, J.
    Hu, M. T.
    Wade-Martins, R.
    Alegre-Abarrategui, J.
    Parkkinen, L.
    MOVEMENT DISORDERS, 2016, 31 : S584 - S584
12345